23 July 2023 - $6 million USD in funding will help address health disparities among indigenous communities with a focus ...
20 July 2023 - As CADTH continues along the path of strategic transformation, we’re working hard to align the evidence products ...
12 July 2023 - Duchesnay is pleased to announce that Slynd (drospirenone 4 mg), used to prevent pregnancy in girls ...
11 July 2023 - Médunik Canada is pleased to announce that Ruzurgi (amifampridine) is now covered by the vast majority of ...
28 June 2023 - Ontario lists Albrioza on its drug benefit formulary, becoming the first province to publicly reimburse Albrioza, ...
15 June 2023 - Amylyx will now work with federal, provincial, and territorial drug plans to ensure public coverage is available ...
8 June 2023 - CADTH, Canada’s drug and health technology agency, announces the creation and inaugural membership of a new ...
5 June 2023 - Today, CADTH is communicating a series of improvements that will further our ambition to innovate in ...
31 May 2023 - CADTH has partnered with Health Canada, the Institut national d’excellence en santé et en services sociaux (INESSS), ...
29 May 2023 - Roche Canada today announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for ...
16 May 2023 - CADTH, Health Canada, and the Institut national d’excellence en santé et en services sociaux (INESSS) are ...
27 April 2023 - Health Minister Jean-Yves Duclos says he has not exercised any undue political pressure on the independent ...
24 April 2023 - The position statement is a step toward greater transparency of unpublished data and a tangible outcome ...
25 April 2023 - During a 1-year learning period, CADTH expanded its Scientific Advice program to include advice on real-world evidence ...
17 April 2023 - AbbVie today announced that Vraylat is now listed as an exception medication status on the list of ...